Amundi bought 3.12 lakh shares of CORONA Remedies Limited for ₹63.96 Cr at ₹2,050 apiece in a bulk deal.
Corona Remedies Limited, founded in 2004 and headquartered in Ahmedabad, is a pharmaceutical company manufacturing and distributing medicines across women's healthcare, cardiology, pain management, and urology. The company operates two manufacturing facilities in Gujarat and Himachal Pradesh, holds EU-GMP and WHO certifications, and maintains market leadership positions in multiple therapeutic segments including rank #5 in women's healthcare and pain management.
Europe's largest asset manager, headquartered in Paris, investing in listed Indian equities across multiple India strategies.
